MRK — Merck & Co Income Statement
0.000.00%
Last trade - 00:00
- $313.67bn
- $341.68bn
- $60.12bn
- 90
- 19
- 95
- 76
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 39,121 | 41,518 | 48,704 | 59,283 | 60,115 |
Cost of Revenue | |||||
Gross Profit | 28,061 | 29,935 | 35,463 | 42,077 | 44,200 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 31,821 | 36,545 | 36,166 | 41,338 | 58,333 |
Operating Profit | 7,300 | 4,973 | 12,538 | 17,945 | 1,783 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,171 | 5,863 | 13,879 | 16,444 | 1,889 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,606 | 4,523 | 12,358 | 14,526 | 377 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 9,843 | 7,067 | 13,049 | 14,519 | 365 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9,843 | 7,067 | 13,049 | 14,519 | 365 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.96 | 4.7 | 6.81 | 7.89 | 1.37 |
Dividends per Share |